Use of Prolactin Receptor Antagonist to Better Understand Prolactin Regulation of Pituitary Homeostasis

被引:27
作者
Ferraris, Jimena [1 ]
Bernichtein, Sophie [2 ]
Pisera, Daniel [1 ]
Goffin, Vincent [2 ]
机构
[1] Univ Buenos Aires, CONICET, Sch Med, Inst Biomed Res, Buenos Aires, DF, Argentina
[2] Univ Paris 05, Prolactin Growth Hormone Pathophysiol Lab, Res Ctr Growth & Signaling, Inserm,Sorbonne Paris Cite,Fac Med,U845, Paris, France
关键词
Prolactin; Del1-9-G129R-hPRL; Prolactin receptor antagonist; Pituitary; Apoptosis; Proliferation; GROWTH-HORMONE; MESSENGER-RNA; SIGNAL TRANSDUCER; GENE-EXPRESSION; LACTOTROPH PROLIFERATION; LUTEINIZING-HORMONE; AUTOCRINE PROLACTIN; DOWN-REGULATION; APOPTOSIS; CELLS;
D O I
10.1159/000354701
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The anterior pituitary is permanently regulated by processes of apoptosis and proliferation in order to maintain tissue homeostasis. Several factors have been implicated in this regulation and lately, prolactin (PRL) has been included into that list. However, since PRL is secreted by anterior pituitary lactotropes, the actual outcome of its autocrine/paracrine actions on pituitary cells has remained difficult to assess. The availability of the pure PRL receptor antagonist Del1-9-G129R-hPRL has been helpful to circumvent this problem. While PRL has been traditionally associated with increased cell proliferation, recent studies revealed that this hormone actually induces apoptosis and decreases proliferation of anterior pituitary cells, by mechanisms involving the PRL receptor. The aim of this short review is to overview our current understanding of the regulation of pituitary homeostasis by PRL. Moreover, studies involving Del1-9-G129R-hPRL have helped anticipate to what extent future treatments involving PRL receptor inhibitors may interfere with processes regulated by PRL at the central level. (C) 2013 S. Karger AG, Basel
引用
收藏
页码:171 / 179
页数:9
相关论文
共 92 条
[11]   Repeated exposure to prolactin is required to induce luteal regression in the hypophysectomized rat [J].
Bowen, JM ;
Keyes, PL .
BIOLOGY OF REPRODUCTION, 2000, 63 (04) :1179-1184
[12]   Downregulation of long-form prolactin receptor mRNA during prolactin-induced luteal regression [J].
Bowen, JM ;
Telleria, CM ;
Towns, R ;
Keyes, PL .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 143 (02) :285-292
[13]   PRL activates the cyclin D1 promoter via the Jak2/Stat pathway [J].
Brockman, JL ;
Schroeder, MD ;
Schuler, LA .
MOLECULAR ENDOCRINOLOGY, 2002, 16 (04) :774-784
[14]   Crystal Structure of an Affinity-matured Prolactin Complexed to Its Dimerized Receptor Reveals the Topology of Hormone Binding Site 2 [J].
Broutin, Isabelle ;
Jomain, Jean-Baptiste ;
Tallet, Estelle ;
van Agthoven, Jan ;
Raynal, Bertrand ;
Hoos, Sylviane ;
Kragelund, Birthe B. ;
Kelly, Paul A. ;
Ducruix, Arnaud ;
England, Patrick ;
Goffin, Vincent .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (11) :8422-8433
[15]   Prolactin, a lymphocyte growth and survival factor [J].
Buckley, AR .
LUPUS, 2001, 10 (10) :684-690
[16]   Anterior pituitary cell renewal during the estrous cycle [J].
Candolfi, M. ;
Zaldivar, V. ;
Jaita, G. ;
Seilicovich, A. .
PITUITARY TODAY: MOLECULAR, PHYSIOLOGICAL AND CLINICAL ASPECTS, 2006, 35 :9-21
[17]   Tumor necrosis factor-alpha-induced nitric oxide restrains the apoptotic response of anterior pituitary cells [J].
Candolfi, M ;
Jaita, G ;
Zaldivar, V ;
Zárate, S ;
Pisera, D ;
Seilicovich, A .
NEUROENDOCRINOLOGY, 2004, 80 (02) :83-91
[18]   Sensitization of osteosarcoma cells to apoptosis by oncostatin M depends on STAT5 and p53 [J].
Chipoy, C. ;
Brounais, B. ;
Trichet, V. ;
Battaglia, S. ;
Berreur, M. ;
Oliver, L. ;
Juin, P. ;
Redini, F. ;
Heymann, D. ;
Blanchard, F. .
ONCOGENE, 2007, 26 (46) :6653-6664
[19]   The role of prolactin in mammary carcinoma [J].
Clevenger, CV ;
Furth, PA ;
Hankinson, SE ;
Schuler, LA .
ENDOCRINE REVIEWS, 2003, 24 (01) :1-27
[20]   Pituitary tumorigenesis in prolactin gene-disrupted mice [J].
Cruz-Soto, ME ;
Scheiber, MD ;
Gregerson, KA ;
Boivin, GP ;
Horseman, ND .
ENDOCRINOLOGY, 2002, 143 (11) :4429-4436